Hospital-acquired infections are type of infections acquired during hospitalization and are commonly known as nosocomial infection. These infections can be acquired in hospital, nursing home, rehabilitation facility, outpatient clinic, or other clinical settings. They can be acquired from an infected patient, outside environment, or from a staff of that facility. The hospital-acquired infection diagnostics market is primarily driven by the growth in awareness among healthcare workers and proposed government initiatives by many governmental organizations. Further, in developing economies such as China, India, and Brazil, the cleanliness and hygiene is minimum. Hence, it results in more hospital-acquired infections, which further increases the demand for hospital-acquired infection diagnostics. However, the decline in hospital-acquired infections in the developed countries such as the U.S., Germany, and the UK impedes the market growth. The hospital-acquired infection diagnostics market was valued at $2,571 million in 2016, and is expected to reach at $4,311 million by 2023, registering a CAGR of 7.5% from 2017 to 2023. Research Beam Model: Research Beam Product ID: 2139708 5370 USD New
Hospital-acquired infection Diagnostics Market by Product (Instrument and Reagents and Consumables) by Test Type (Molecular Diagnostics, Urinalysis, and Immunoassay) by Application (Disease Testing and Drug-Resistance Testing), by Infection Type (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections (UTI), and Others) and by End User (Hospital, Clinics, Ambulatory Surgery Centres (ASC) and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Hospital-acquired infection Diagnostics Market by Product (Instrument and Reagents and Consumables) by Test Type (Molecular Diagnostics, Urinalysis, and Immunoassay) by Application (Disease Testing and Drug-Resistance Testing), by Infection Type (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections (UTI), and Others) and by End User (Hospital, Clinics, Ambulatory Surgery Centres (ASC) and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

 
  • Category : Diagnostic and Biotech
  • Published On : September  2017
  • Pages : 140
 
 

Hospital-acquired infections are type of infections acquired during hospitalization and are commonly known as nosocomial infection. These infections can be acquired in hospital, nursing home, rehabilitation facility, outpatient clinic, or other clinical settings. They can be acquired from an infected patient, outside environment, or from a staff of that facility. The hospital-acquired infection diagnostics market is primarily driven by the growth in awareness among healthcare workers and proposed government initiatives by many governmental organizations. Further, in developing economies such as China, India, and Brazil, the cleanliness and hygiene is minimum. Hence, it results in more hospital-acquired infections, which further increases the demand for hospital-acquired infection diagnostics. However, the decline in hospital-acquired infections in the developed countries such as the U.S., Germany, and the UK impedes the market growth. The hospital-acquired infection diagnostics market was valued at $2,571 million in 2016, and is expected to reach at $4,311 million by 2023, registering a CAGR of 7.5% from 2017 to 2023.

The hospital-acquired infection diagnostics market is segmented based on product, test type, application, infection type, end user and region. Based on product this market is segmented into instrument and reagents and consumables. Based on test type, the market is classified into molecular diagnostics, urinalysis, and immunoassay. Based on application, the market is divided into disease testing and drug resistance testing. Further, based on infection type, it is classified into hospital acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal Infections, urinary tract infections (UTI), and others. Based on end user this market is segmented into hospital, clinics, ambulatory surgery centres (ASC) and others. By region, the market is analysed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global hospital-acquired infections market, with current trends and future estimations to elucidate the imminent investment pockets.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps understand the type of products and technologies used globally.
  • Key market players and their strategies are provided to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Product

  • Instrument and Reagents
  • Consumables

By Test Type

  • Molecular Diagnostics
  • Urinalysis
  • Immunoassay

By Application

  • Disease Testing and
  • Drug-Resistance Testing

By Infection Type

  • Hospital Acquired Pneumonia
  • Bloodstream Infections
  • Surgical Site Infections
  • Gastrointestinal Infections
  • Urinary Tract Infections (UTI)
  • Others

End User

  • Hospital
  • Clinics
  • Ambulatory Surgery Centers (ASC)
  • Others

BY REGION

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • Turkey
    • South Africa
    • Rest of LAMEA

KEY PLAYERS PROFILED

  • Abbott Laboratories
  • AdvanDX
  • Alere Inc.
  • AstraZeneca plc
  • Bayer Schering Pharma LLC
  • Becton Dickinson & Company
  • Cepheid Inc.
  • Roche AG
  • Daiichi Sankyo
  • Hologic, Inc.

The other players in the value chain include (profiles not included in the report)

  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co.
  • Meridien
  • Pfizer
  • Seegene

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2 KEY BENEFITS

1.1.1. Secondary research
1.1.2. Primary research
1.1.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATORY FRAMEWORK
3.5. MARKET SHARE ANALYSIS, 2016
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Rising geriatric population base
3.6.1.2. Demand of HAI diagnostics from middle and low-income countries
3.6.1.3. Development of technologically advanced diagnostic products

3.6.2. Restraints

3.6.2.1. Decreasing prevalence of nosocomial infections in the developed countries
3.6.2.2. Lack of awareness regarding HAI

3.6.3. Opportunities

3.6.3.1. Introduction of awareness programs by various organizations

CHAPTER 4 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. INSTRUMENT

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. REAGENTS AND CONSUMABLES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

CHAPTER 5 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY TEST TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. MOLECULAR DIAGNOSTICS

5.2.1. Market size and forecast

5.3. IMMUNOASSAY

5.3.1. Market size and forecast

5.4. URINALYSIS

5.4.1. Market size and forecast

CHAPTER 6 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS, BY APPLICATION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. DISEASE TESTING

6.2.1. Market size and forecast

6.3. DRUG-RESISTANCE TESTING

6.3.1. Market size and forecast

CHAPTER 7 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY INFECTION TYPE

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. HOSPITAL ACQUIRED PNEUMONIA

7.2.1. Market size and forecast

7.3. BLOODSTREAM INFECTIONS

7.3.1. Market size and forecast

7.4. SURGICAL SITE INFECTIONS

7.4.1. Market size and forecast

7.5. GASTROINTESTINAL INFECTIONS

7.5.1. Market size and forecast

7.6. URINARY TRACT INFECTIONS (UTI)

7.6.1. Market size and forecast

7.7. OTHERS

7.7.1. Market size and forecast

CHAPTER 8 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY END USER

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. HOSPITALS

8.2.1. Market size and forecast

8.3. CLINICS

8.3.1. Market size and forecast

8.4. AMBULATORY SURGERY CENTERS

8.4.1. Market size and forecast

8.5. OTHERS

8.5.1. Market size and forecast

CHAPTER 9 HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY GEOGRAPHY

9.1. OVERVIEW

9.1.1. Market size and forecast

9.2. NORTH AMERICA

9.2.1. Key market trends
9.2.2. Key growth factors and opportunities
9.2.3. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Country
9.2.4. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.2.5. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.2.6. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.2.7. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.2.8. North America Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.2.8.1. U.S. Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.2.8.2. U.S. Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.2.8.3. U.S. Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.2.8.4. U.S. Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.2.8.5. U.S. Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.2.8.6. Canada Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.2.8.7. Canada Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.2.8.8. Canada Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.2.8.9. Canada Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.2.8.10. Canada Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.2.8.11. Mexico Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.2.8.12. Mexico Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.2.8.13. Mexico Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.2.8.14. Mexico Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.2.8.15. Mexico Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.3. EUROPE

9.3.1. Key market trends
9.3.2. Key growth factors and opportunities
9.3.3. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Country
9.3.4. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.5. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.6. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.7. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8. Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.3.8.1. Germany Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.2. Germany Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.3. Germany Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.4. Germany Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.5. Germany Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.3.8.6. UK Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.7. UK Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.8. UK Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.9. UK Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.10. UK Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.3.8.11. France Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.12. France Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.13. France Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.14. France Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.15. France Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.3.8.16. Italy Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.17. Italy Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.18. Italy Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.19. Italy Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.20. Italy Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.3.8.21. Spain Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.22. Spain Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.23. Spain Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.24. Spain Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.25. Spain Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.3.8.26. Rest of Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.3.8.27. Rest of Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.3.8.28. Rest of Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.3.8.29. Rest of Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.3.8.30. Rest of Europe Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.4. ASIA-PACIFIC

9.4.1. Key market trends
9.4.2. Key growth factors and opportunities
9.4.3. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Country
9.4.4. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.5. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.6. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.7. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8. Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.4.8.1. Japan Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.2. Japan Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.3. Japan Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.4. Japan Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.5. Japan Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.4.8.6. India Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.7. India Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.8. India Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.9. India Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.10. India Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.4.8.11. China Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.12. China Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.13. China Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.14. China Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.15. China Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.4.8.16. Australia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.17. Australia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.18. Australia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.19. Australia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.20. Australia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.4.8.21. South Korea Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.22. South Korea Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.23. South Korea Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.24. South Korea Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.25. South Korea Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.4.8.26. Rest of Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.4.8.27. Rest of Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.4.8.28. Rest of Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.4.8.29. Rest of Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.4.8.30. Rest of Asia-Pacific Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.5. LAMEA

9.5.1. Key market trends
9.5.2. Key growth factors and opportunities
9.5.3. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Country
9.5.4. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.5.5. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.5.6. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.5.7. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.5.8. LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

9.5.8.1. Brazil Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.5.8.2. Brazil Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.5.8.3. Brazil Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.5.8.4. Brazil Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.5.8.5. Brazil Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.5.8.6. Saudi Arabia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.5.8.7. Saudi Arabia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.5.8.8. Saudi Arabia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.5.8.9. Saudi Arabia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.5.8.10. Saudi Arabia Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.5.8.11. South Africa Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.5.8.12. South Africa Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.5.8.13. South Africa Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User
9.5.8.14. Rest of LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Product
9.5.8.15. Rest of LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Test Type
9.5.8.16. Rest of LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Application
9.5.8.17. Rest of LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by Infection Type
9.5.8.18. Rest of LAMEA Market Size and Forecast for Hospital Acquired Infection Diagnostics Market by End User

CHAPTER 10 COMPANY PROFILES

10.1. ABBOTT LABORATORIES

10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Operating business segments
10.1.4. Business performance
10.1.5. Key strategic moves and developments

10.2. ADVAN DX

10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Operating business segments
10.2.4. Key strategic moves and developments

10.3. ALERE INC.

10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Business performance
10.3.5. Key strategic moves and developments

10.4. ASTRAZENECA PLC

10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Operating business segments
10.4.4. Key strategic moves and developments

10.5. BAYER SCHERING PHARMA LLC

10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Key strategic moves and developments

10.6. BECTON DICKINSON AND COMPANY

10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Key strategic moves and developments

10.7. CEPHEID INC.

10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Key strategic moves and developments

10.8. ROCHE AG

10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Key strategic moves and developments

10.9. DAIICHI SANKYO

10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Business performance
10.9.5. Key strategic moves and developments

10.10. HOLOGIC, INC.

10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Operating business segments
10.10.4. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 2. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET FOR INSTRUMENT, BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 5. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2016-2023 ($MILLION)
TABLE 6. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET FOR IMMUNOASSAY, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET FOR URINALYSIS, BY REGION, 2016-2023 ($MILLION)
TABLE 8. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET FOR DISEASE TESTING, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET FOR DRUG-RESISTANCE TESTING, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 12. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET FOR HOSPITAL ACQUIRED PNEUMONIA, BY REGION, 2016-2023 ($MILLION)
TABLE 13. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET FOR BLOODSTREAM INFECTIONS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET FOR SURGICAL SITE INFECTIONS, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET FOR GASTROINTESTINAL INFECTIONS, BY REGION, 2016-2023 ($MILLION)
TABLE 16. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET FOR URINARY TRACT INFECTIONS (UTI), BY REGION, 2016-2023 ($MILLION)
TABLE 17. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2016-2023 ($MILLION)
TABLE 18. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 19. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET FOR HOSPITALS END USER, BY REGION, 2016-2023 ($MILLION)
TABLE 20. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET FOR CLINICS END USER, BY REGION, 2016-2023 ($MILLION)
TABLE 21. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET FOR AMBULATORY SURGERY CENTERS END USER, BY REGION, 2016-2023 ($MILLION)
TABLE 22. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET FOR OTHERS END USER, BY REGION, 2016-2023 ($MILLION)
TABLE 23. HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 24. NORTH AMERICA HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 25. NORTH AMERICA HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 26. NORTH AMERICA HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 27. NORTH AMERICA HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 28. NORTH AMERICA HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 29. NORTH AMERICA HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 30. U.S. MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 31. U.S. MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 32. U.S. MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 33. U.S. MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 34. U.S. MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 35. CANADA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 36. CANADA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 37. CANADA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 38. CANADA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 39. CANADA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 40. MEXICO MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 41. MEXICO MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 42. MEXICO MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 43. MEXICO MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 44. MEXICO MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 45. EUROPE HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 46. EUROPE HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 47. EUROPE HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 48. EUROPE HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 49. EUROPE HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 50. EUROPE HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 51. GERMANY MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 52. GERMANY MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 53. GERMANY MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 54. GERMANY MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 55. GERMANY MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 56. UK MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 57. UK MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 58. UK MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 59. UK MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 60. UK MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 61. FRANCE MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 62. FRANCE MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 63. FRANCE MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 64. FRANCE MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 65. FRANCE MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 66. ITALY MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 67. ITALY MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 68. ITALY MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 69. ITALY MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 70. ITALY MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 71. SPAIN MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 72. SPAIN MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 73. SPAIN MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 74. SPAIN MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 75. SPAIN MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 76. REST OF EUROPE MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 77. REST OF EUROPE MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 78. REST OF EUROPE MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 79. REST OF EUROPE MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 80. REST OF EUROPE MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 81. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 82. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 83. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 84. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 85. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 86. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 87. JAPAN MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 88. JAPAN MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 89. JAPAN MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 90. JAPAN MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 91. JAPAN MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 92. INDIA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 93. INDIA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 94. INDIA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 95. INDIA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 96. INDIA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 97. CHINA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 98. CHINA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 99. CHINA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 100. CHINA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 101. CHINA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 102. AUSTRALIA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 103. AUSTRALIA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 104. AUSTRALIA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 105. AUSTRALIA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 106. AUSTRALIA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 107. SOUTH KOREA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 108. SOUTH KOREA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 109. SOUTH KOREA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 110. SOUTH KOREA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 111. SOUTH KOREA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 112. REST OF ASIA-PACIFIC MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 113. REST OF ASIA-PACIFIC MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 114. REST OF ASIA-PACIFIC MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 115. REST OF ASIA-PACIFIC MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 116. REST OF ASIA-PACIFIC MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 117. LAMEA HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 118. LAMEA HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 119. LAMEA HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 120. LAMEA HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 121. LAMEA HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 122. LAMEA HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 123. BRAZIL MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 124. BRAZIL MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 125. BRAZIL MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 126. BRAZIL MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 127. BRAZIL MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 128. SAUDI ARABIA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 129. SAUDI ARABIA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 130. SAUDI ARABIA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 131. SAUDI ARABIA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 132. SAUDI ARABIA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 133. SOUTH AFRICA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 134. SOUTH AFRICA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 135. SOUTH AFRICA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 136. SOUTH AFRICA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 137. SOUTH AFRICA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 138. REST OF LAMEA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY PRODUCT, 2016-2023 ($MILLION)
TABLE 139. REST OF LAMEA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 140. REST OF LAMEA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 ($MILLION)
TABLE 141. REST OF LAMEA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 142. REST OF LAMEA MARKET SIZE AND FORECAST FOR HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET BY END USER, 2016-2023 ($MILLION)
TABLE 143. ABBOTT: COMPANY SNAPSHOT
TABLE 144. ABBOTT: OPERATING SEGMENTS
TABLE 145. ADVAN: COMPANY SNAPSHOT
TABLE 146. ADVAN: OPERATING SEGMENTS
TABLE 147. ALERE: COMPANY SNAPSHOT
TABLE 148. ALERE: OPERATING SEGMENTS
TABLE 149. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 150. ASTRAZENECA: OPERATING SEGMENTS
TABLE 151. BAYER: COMPANY SNAPSHOT
TABLE 152. BAYER: OPERATING SEGMENTS
TABLE 153. BECTON: COMPANY SNAPSHOT
TABLE 154. BECTON: OPERATING SEGMENTS
TABLE 155. CEPHEID: COMPANY SNAPSHOT
TABLE 156. CEPHEID: OPERATING SEGMENTS
TABLE 157. ROCHE: COMPANY SNAPSHOT
TABLE 158. ROCHE: OPERATING SEGMENTS
TABLE 159. DAIICHI: COMPANY SNAPSHOT
TABLE 160. DAIICHI: OPERATING SEGMENTS
TABLE 161. HOLOGIC: COMPANY SNAPSHOT
TABLE 162. HOLOGIC: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, 2016-2023
FIGURE 2. SEGMENTATION OF GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, 2016-2023
FIGURE 3. TOP INVESTMENT POCKETS IN GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET
FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2017)
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 7. BARGAINING POWER OF BUYERS
FIGURE 8. BARGAINING POWER OF SUPPLIERS
FIGURE 9. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. RESTRAINTS AND DRIVERS: GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET
FIGURE 13. HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY PRODUCT
FIGURE 14. HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY TEST TYPE
FIGURE 15. GLOBAL HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET: APPLICATION
FIGURE 16. HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY INFECTION TYPE
FIGURE 17. HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY END USER
FIGURE 18. HOSPITAL ACQUIRED INFECTION DIAGNOSTICS MARKET, BY GEOGRAPHY
FIGURE 19. ABBOTT: NET SALES, 2014-2017 ($MILLION)
FIGURE 20. ABBOTT: REVENUE BY SEGMENT, 2016 (%)
FIGURE 21. ABBOTT: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 22. ALERE: NET SALES, 2014-2017 ($MILLION)
FIGURE 23. ALERE: REVENUE BY SEGMENT, 2016 (%)
FIGURE 24. ALERE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 25. DAIICHI: NET SALES, 2014-2017 ($MILLION)
FIGURE 26. DAIICHI: REVENUE BY SEGMENT, 2016 (%)
FIGURE 27. DAIICHI: REVENUE BY GEOGRAPHY, 2016 (%)